INGREZZA

Neurocrine Access Support - Patient Assistance Program Patient Guide: How to Get INGREZZA (valbenazine) at Low or No Cost

This guide explains the Neurocrine Access Support - Patient Assistance Program from Neurocrine Biosciences, helping eligible patients access INGREZZA (valbenazine)—a prescription medication—for tardive dyskinesia or Huntington's disease chorea at no cost. It covers eligibility, application steps, and support options in simple terms.

About INGREZZA (valbenazine)

INGREZZA (valbenazine) is an oral capsule (available as standard capsules or INGREZZA SPRINKLE) approved to treat tardive dyskinesia (TD) in adults and chorea associated with Huntington's disease. TD causes involuntary movements like lip smacking or tongue thrusting, often from long-term antipsychotic use. Chorea involves jerky, uncontrolled movements. INGREZZA works by reducing these symptoms, helping patients regain control and improve daily life. Always consult your doctor for personalized advice, as it has a Boxed Warning for risks like sleepiness or neuroleptic malignant syndrome.

Who Qualifies for the Program?

The program supports patients with financial need who lack adequate coverage. Key qualifiers include:

• U.S. residents (or territories).
• No prescription insurance for INGREZZA, uninsured, or insured but with qualifying financial hardship.
• Must meet undisclosed financial criteria assessed individually—no fixed Federal Poverty Level (FPL) percentage is public.

Commercially insured patients may not qualify for free meds but can get a Savings Card for $0 copay (90% pay $10 or less). Medicare/Medicaid patients typically don't qualify for free drug but check other options.

Income Eligibility Breakdown

Specific income thresholds aren't publicly listed; Neurocrine reviews cases individually based on financial details provided. Here's a summary:

Provide accurate financial info (income, bills) on the application. Specialists may call for clarification.

Insurance Requirements

• Uninsured or no INGREZZA coverage: Primary targets for free medication.
• Commercial insurance: Use Savings Card for low/no copay instead.
• Medicare/Medicaid: Generally ineligible for Patient Assistance Program (PAP); explore state programs or 30-Day Free Trial.
• Attach insurance card copy if applicable; check 'no insurance' if uncovered.

Call 1-844-647-3992 to verify coverage.

Step-by-Step Application Process

1. Talk to your doctor: They prescribe INGREZZA and complete the application.
2. Download or request form: Get the INGREZZA Patient Assistance Program Application from https://ingrezza.neurocrineaccesssupport.com/ or call (844) 647-3992 (8 AM-8 PM ET, Mon-Fri).
3. Gather documents:
   • Completed application (patient, prescriber sections).
   • Prescriber signature and certification of medical need.
   • Insurance card copy (or note no insurance).
   • Proof of residency (e.g., utility bill).
   • Financial details (income, household size).
4. Submit: Fax, mail, or upload via website/portal. Multiple methods available.
5. Wait for review: Neurocrine assesses eligibility.
6. Approval: If yes, medication ships free to you.

Your doctor can also enroll you in the INGREZZA 30-Day Free Trial (1-month supply for new patients) via a separate form.

Timeline and Delivery

Processing time varies; expect 2-4 weeks based on similar programs (not specified). Call for status updates. Approved meds are shipped directly to your home via specialty pharmacy—no pharmacy pickup needed. Track via Patient Tracker tool if enrolled.

Alternatives if Denied

• Savings Card: $0 copay for commercial insurance.
• 30-Day Free Trial: Free month for new patients.
• Appeal: Resubmit with more financial proof.
• Other resources: RxAssist.org, state Medicaid, or NeedyMeds for generics/alternatives (none listed as biosimilars).
• Contact support: 1-844-647-3992 for personalized help.

Important Disclaimer

This guide is for informational purposes based on publicly available data as of 2026. Eligibility, terms, and availability can change—verify with Neurocrine at 1-844-647-3992 or the website. Not medical/financial advice. Consult your healthcare provider. Program may collect personal health info for assistance, compliance, and research (with consent). Additional terms apply.